96 related articles for article (PubMed ID: 6092247)
1. [Epstein-Barr virus infection and immune responses in primary immunodeficiency syndromes].
Sakiyama Y
Hokkaido Igaku Zasshi; 1984 Jul; 59(4):379-82. PubMed ID: 6092247
[No Abstract] [Full Text] [Related]
2. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
[TBL] [Abstract][Full Text] [Related]
3. Unusual prevalence of Epstein-Barr virus early antigen (EBV-EA) antibodies in ataxia telangiectasia.
Joncas J; Lapointe N; Gervais F; Leyritz M
J Immunol; 1977 Nov; 119(5):1857-9. PubMed ID: 199670
[No Abstract] [Full Text] [Related]
4. Epstein-Barr virus infection and oncogenesis in primary immunodeficiency.
Okano M; Osato T; Koizumi S; Imai S; Aya T; Fujiwara S; Mizuno F; Sakiyama Y; Matsumoto S; Sugawara O
AIDS Res; 1986 Dec; 2 Suppl 1():S115-9. PubMed ID: 3030341
[TBL] [Abstract][Full Text] [Related]
5. [The diagnostic value of Epstein-Barr virus diagnosis].
Bauer G
Internist (Berl); 1992 Sep; 33(9):586-92. PubMed ID: 1328107
[No Abstract] [Full Text] [Related]
6. [Fluctuation in Epstein-Barr virus-related antibody titers by age: response differences between the IgG antibodies to VCA and anti-EBNA antibodies].
Kumagai E; Tanaka R; Kumagai T; Katsuki T; Sawada S
Rinsho Byori; 1984 Jun; 32(6):666-70. PubMed ID: 6092744
[No Abstract] [Full Text] [Related]
7. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
[TBL] [Abstract][Full Text] [Related]
8. The Epstein-Barr virus: historical, biologic, pathologic and oncologic considerations.
Seemayer TA; Oligny LL; Gartner JG
Perspect Pediatr Pathol; 1981; 6():1-33. PubMed ID: 6275338
[No Abstract] [Full Text] [Related]
9. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
Epstein MA; Morgan AJ
Clin Exp Immunol; 1983 Aug; 53(2):257-71. PubMed ID: 6309441
[No Abstract] [Full Text] [Related]
10. Fatal Epstein-Barr virus infection in a child with acute lymphoblastic leukemia in remission.
Look AT; Naegele RF; Callihan T; Herrod HG; Henle W
Cancer Res; 1981 Nov; 41(11 Pt 1):4280-3. PubMed ID: 6272972
[TBL] [Abstract][Full Text] [Related]
11. Persistence and transfer of Epstein-Barr virus after allogeneic bone marrow transplantation.
Gratama JW; Oosterveer MA; Lepoutre J; van Rood JJ; Zwaan FE; Vossen JM; Kapsenberg JG; Klein G; Ernberg I
Transplant Proc; 1989 Feb; 21(1 Pt 3):3097-8. PubMed ID: 2539687
[No Abstract] [Full Text] [Related]
12. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.
Svedmyr A; Demissie A; Klein G; Clifford P
J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428
[No Abstract] [Full Text] [Related]
13. Epstein-Barr virus and rheumatoid arthritis.
Bonneville M; Scotet E; Peyrat MA; Saulquin X; Houssaint E
Rev Rhum Engl Ed; 1998 Jun; 65(6):365-8. PubMed ID: 9670326
[No Abstract] [Full Text] [Related]
14. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies.
Purtilo DT; Sakamoto K; Saemundsen AK; Sullivan JL; Synnerholm AC; Anvret M; Pritchard J; Sloper C; Sieff C; Pincott J; Pachman L; Rich K; Cruzi F; Cornet JA; Collins R; Barnes N; Knight J; Sandstedt B; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4226-36. PubMed ID: 6272967
[TBL] [Abstract][Full Text] [Related]
15. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
16. Defective allosuppression in patients with ataxia-telangiectasia.
Tosato G; Blaese RM
Kroc Found Ser; 1985; 19():331-8. PubMed ID: 2999344
[TBL] [Abstract][Full Text] [Related]
17. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G
J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407
[TBL] [Abstract][Full Text] [Related]
18. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
[TBL] [Abstract][Full Text] [Related]
19. Association of Epstein-Barr virus with thymic carcinoma.
Leyvraz S; Henle W; Chahinian AP; Perlmann C; Klein G; Gordon RE; Rosenblum M; Holland JF
N Engl J Med; 1985 May; 312(20):1296-9. PubMed ID: 2985993
[No Abstract] [Full Text] [Related]
20. Epstein-Barr virus-specific serology in immunologically compromised individuals.
Henle W; Henle G
Cancer Res; 1981 Nov; 41(11 Pt 1):4222-5. PubMed ID: 6272966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
